Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

01-01-2016 | Basic Science

S100A4 gene silencing in oxygen-induced ischemic retinopathy inhibits retinal neovascularization via down-regulation of CREB expression

Authors: Gumeng Cheng, Kailin Tian, Lu Zhang, Ning Yang, Yiqiao Xing, Tao He

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 1/2016

Abstract

Purpose

To investigate the possible role of S100A4 in retinal neovascularization (RNV), as well as the underlying mechanism, in a mouse model of oxygen-induced retinopathy (OIR).

Methods

Retinas used in the experiments were obtained from a mouse model of OIR with and without treatment by intravitreal injection of adnoviral-S100A4-RNAi or adenoviral-green fluorescent protein at postnatal day 12 (P12). At P17, the efficacy of adenoviral gene transfer was assessed with fluorescence microscopy. RNV was evaluated by whole-mount immunofluorescent staining of the mouse retina with Griffonia simplicifolia isolectin B4 conjugated to Alexa Fluor 594 and quantified by counting the number of pre-retinal neovascular cells. Protein and mRNA expression levels of S100A4, cyclic AMP (cAMP) response element-binding protein (CREB), B-cell lymphoma 2 (Bcl-2), and caspase-3 were determined using Western blot analysis and real-time PCR.

Results

Retinal S100A4 levels were positively correlated with the progression of RNV. In the intravitreal Ad-S100A4-RNAi transfer mice, both S100A4 protein and mRNA expression levels in the retina were significantly decreased at P17. Ad-S100A4-RNAi transfer was clearly demonstrated by the green fluorescent protein (GFP) in many layers of the retina, including the ganglion cell layer (GCL), inner plexiform layer (IPL), inner nuclear layer (INL), outer plexiform layer (OPL), and outer nuclear layer (ONL), 3 days after intravitreal injection. Whole-mount immunofluorescent staining of the retina and quantification of the pre-retinal neovascular cells demonstrated that RNV was significantly ameliorated. At the same time, the expression of CREB and Bcl-2 were significantly decreased at the transcriptional and translational levels in the OIR-S100A4 group, whereas caspase-3 expression was increased.

Conclusions

Our results indicated that RNV was ameliorated by Ad-S100A4-RNAi transfer in a mouse model of OIR through mediation of the anti-apoptotic effect of Bcl-2 by reducing the expression of CREB, and that S100A4 may be a novel therapeutic target for ocular neovascularization diseases.

Lee P, Wang CC, Adamis AP (1998) Ocular neovascularization: an epidemiologic review. Surv Ophthalmol 43(3):245–269PubMedCrossRef

Hardy P, Dumont I, Bhattacharya M, Hou X, Lachapelle P, Varma DR, Chemtob S (2000) Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy. Cardiovasc Res 47(3):489–509PubMedCrossRef

Campochiaro PA (2000) Retinal and choroidal neovascularization. J Cell Physiol 184(3):301–310. doi:10.1002/1097-4652(200009)184:3<301::AID-JCP3>3.0.CO;2-H PubMedCrossRef

Bussolino F, Mantovani A, Persico G (1997) Molecular mechanisms of blood vessel formation. Trends Biochem Sci 22(7):251–256PubMedCrossRef

Miller JW, Adamis AP, Aiello LP (1997) Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. Diabetes Metab Rev 13(1):37–50PubMedCrossRef

Ali Rahman IS, Li CR, Lai CM, Rakoczy EP (2011) In vivo monitoring of VEGF-induced retinal damage in the Kimba mouse model of retinal neovascularization. Curr Eye Res 36(7):654–662. doi:10.3109/02713683.2010.551172 PubMedCrossRef

Chen P, Yin H, Wang Y, Wang Y, Xie L (2012) Inhibition of VEGF expression and corneal neovascularization by shRNA targeting HIF-1alpha in a mouse model of closed eye contact lens wear. Mol Vis 18:864–873PubMedPubMedCentral

Hewing NJ, Weskamp G, Vermaat J, Farage E, Glomski K, Swendeman S, Chan RV, Chiang MF, Khokha R, Anand-Apte B, Blobel CP (2013) Intravitreal injection of TIMP3 or the EGFR inhibitor erlotinib offers protection from oxygen-induced retinopathy in mice. Invest Ophthalmol Vis Sci 54(1):864–870. doi:10.1167/iovs.12-10954 PubMedPubMedCentralCrossRef

Lofqvist C, Willett KL, Aspegren O, Smith AC, Aderman CM, Connor KM, Chen J, Hellstrom A, Smith LE (2009) Quantification and localization of the IGF/insulin system expression in retinal blood vessels and neurons during oxygen-induced retinopathy in mice. Invest Ophthalmol Vis Sci 50(4):1831–1837. doi:10.1167/iovs.08-2903 PubMedCrossRef

10.

Vanhaesebrouck S, Daniels H, Moons L, Vanhole C, Carmeliet P, De Zegher F (2009) Oxygen-induced retinopathy in mice: amplification by neonatal IGF-I deficit and attenuation by IGF-I administration. Pediatr Res 65(3):307–310. doi:10.1203/PDR.0b013e3181973dc8 PubMedCrossRef

11.

Lin M, Chen Y, Jin J, Hu Y, Zhou KK, Zhu M, Le YZ, Ge J, Johnson RS, Ma JX (2011) Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal muller cells. Diabetologia 54(6):1554–1566. doi:10.1007/s00125-011-2081-0 PubMedCrossRef

12.

Xia XB, Xiong SQ, Xu HZ, Jiang J, Li Y (2008) Suppression of retinal neovascularization by shRNA targeting HIF-1alpha. Curr Eye Res 33(10):892–902. doi:10.1080/02713680802416670 PubMedCrossRef

13.

Boye K, Maelandsmo GM (2010) S100A4 and metastasis: a small actor playing many roles. Am J Pathol 176(2):528–535. doi:10.2353/ajpath.2010.090526 PubMedPubMedCentralCrossRef

14.

Saleem M, Kweon MH, Johnson JJ, Adhami VM, Elcheva I, Khan N, Bin Hafeez B, Bhat KM, Sarfaraz S, Reagan-Shaw S, Spiegelman VS, Setaluri V, Mukhtar H (2006) S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc Natl Acad Sci U S A 103(40):14825–14830. doi:10.1073/pnas.0606747103 PubMedPubMedCentralCrossRef

15.

Zhang J, Zhang DL, Jiao XL, Dong Q (2013) S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-kappaB-dependent MMP-9 signal. Eur Rev Med Pharmacol Sci 17(17):2372–2382PubMed

16.

Tamaki Y, Iwanaga Y, Niizuma S, Kawashima T, Kato T, Inuzuka Y, Horie T, Morooka H, Takase T, Akahashi Y, Kobuke K, Ono K, Shioi T, Sheikh SP, Ambartsumian N, Lukanidin E, Koshimizu TA, Miyazaki S, Kimura T (2013) Metastasis-associated protein, S100A4 mediates cardiac fibrosis potentially through the modulation of p53 in cardiac fibroblasts. J Mol Cell Cardiol 57:72–81. doi:10.1016/j.yjmcc.2013.01.007 PubMedCrossRef

17.

He J, Xu Y, Koya D, Kanasaki K (2013) Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease. Clin Exp Nephrol 17(4):488–497. doi:10.1007/s10157-013-0781-0 PubMedCrossRef

18.

Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R (2008) Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol: JASN 19(12):2282–2287. doi:10.1681/ASN.2008050513 PubMedPubMedCentralCrossRef

19.

Tang RN, Lv LL, Zhang JD, Dai HY, Li Q, Zheng M, Ni J, Ma KL, Liu BC (2013) Effects of angiotensin II receptor blocker on myocardial endothelial-to-mesenchymal transition in diabetic rats. Int J Cardiol 162(2):92–99. doi:10.1016/j.ijcard.2011.06.052 PubMedCrossRef

20.

Widyantoro B, Emoto N, Nakayama K, Anggrahini DW, Adiarto S, Iwasa N, Yagi K, Miyagawa K, Rikitake Y, Suzuki T, Kisanuki YY, Yanagisawa M, Hirata K (2010) Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition. Circulation 121(22):2407–2418. doi:10.1161/CIRCULATIONAHA.110.938217 PubMedCrossRef

21.

Abu El-Asrar AM, Nawaz MI, De Hertogh G, Alam K, Siddiquei MM, Van den Eynde K, Mousa A, Mohammad G, Geboes K, Opdenakker G (2014) S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis. Mol Vis 20:1209–1224PubMedPubMedCentral

22.

Zhang ZJ (2014) Artificial trans-acting small interfering RNA: a tool for plant biology study and crop improvements. Planta 239(6):1139–1146. doi:10.1007/s00425-014-2054-x PubMedCrossRef

23.

Connor KM, Krah NM, Dennison RJ, Aderman CM, Chen J, Guerin KI, Sapieha P, Stahl A, Willett KL, Smith LE (2009) Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc 4(11):1565–1573. doi:10.1038/nprot.2009.187 PubMedPubMedCentralCrossRef

24.

Zhong X, Huang H, Shen J, Zacchigna S, Zentilin L, Giacca M, Vinores SA (2011) Vascular endothelial growth factor-B gene transfer exacerbates retinal and choroidal neovascularization and vasopermeability without promoting inflammation. Mol Vis 17:492–507PubMedPubMedCentral

25.

Chiu K, Chang RC, So KF (2007) Intravitreous injection for establishing ocular diseases model. J Vis Exp: JoVE 8:313. doi:10.3791/313 PubMed

26.

Fan W, Xing Y, Zhong Y, Chen C, Shen Y (2013) Expression of NMDA receptor subunit 1 in the rat retina. Acta Histochem 115(1):42–47. doi:10.1016/j.acthis.2012.03.005 PubMedCrossRef

27.

Smith LE, Wesolowski E, McLellan A, Kostyk SK, D’Amato R, Sullivan R, D’Amore PA (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35(1):101–111PubMed

28.

Chen YY, Liu SL, Hu DP, Xing YQ, Shen Y (2014) N -methyl- N -nitrosourea-induced retinal degeneration in mice. Exp Eye Res 121:102–113. doi:10.1016/j.exer.2013.12.019 PubMedCrossRef

29.

Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods (San Diego, Calif) 25(4):402–408. doi:10.1006/meth.2001.1262 CrossRef

30.

Buch H, Vinding T, Nielsen NV (2001) Prevalence and causes of visual impairment according to World Health Organization and United States criteria in an aged, urban Scandinavian population: the Copenhagen City Eye Study. Ophthalmology 108(12):2347–2357PubMedCrossRef

31.

Congdon N, O’Colmain B, Klaver CC, Klein R, Munoz B, Friedman DS, Kempen J, Taylor HR, Mitchell P, Eye Diseases Prevalence Research G (2004) Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 122(4):477–485. doi:10.1001/archopht.122.4.477 PubMedCrossRef

32.

Hernandez C, Simo R (2007) Strategies for blocking angiogenesis in diabetic retinopathy: from basic science to clinical practice. Exp Opin Investig Drugs 16(8):1209–1226. doi:10.1517/13543784.16.8.1209 CrossRef

33.

Nicholson BP, Schachat AP (2010) A review of clinical trials of anti-VEGF agents for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol 248(7):915–930. doi:10.1007/s00417-010-1315-z CrossRef

34.

Kim J, Kim CS, Lee YM, Jo K, Shin SD, Kim JS (2012) Methylglyoxal induces hyperpermeability of the blood-retinal barrier via the loss of tight junction proteins and the activation of matrix metalloproteinases. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol 250(5):691–697. doi:10.1007/s00417-011-1912-5 CrossRef

35.

Peng S, Gan G, Rao VS, Adelman RA, Rizzolo LJ (2012) Effects of proinflammatory cytokines on the claudin-19 rich tight junctions of human retinal pigment epithelium. Invest Ophthalmol Vis Sci 53(8):5016–5028. doi:10.1167/iovs.11-8311 PubMedPubMedCentralCrossRef

36.

Ochiya T, Takenaga K, Endo H (2014) Silencing of S100A4, a metastasis-associated protein, in endothelial cells inhibits tumor angiogenesis and growth. Angiogenesis 17(1):17–26. doi:10.1007/s10456-013-9372-7 PubMedPubMedCentralCrossRef

37.

Yonemura Y, Endou Y, Kimura K, Fushida S, Bandou E, Taniguchi K, Kinoshita K, Ninomiya I, Sugiyama K, Heizmann CW, Schafer BW, Sasaki T (2000) Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer. Clin Cancer Res Off J Am Assoc Cancer Res 6(11):4234–4242

38.

Takenaga K, Nakanishi H, Wada K, Suzuki M, Matsuzaki O, Matsuura A, Endo H (1997) Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas. Clin Cancer Res Off J Am Assoc Cancer Res 3(12 Pt 1):2309–2316

39.

Rudland PS, Platt-Higgins A, Renshaw C, West CR, Winstanley JH, Robertson L, Barraclough R (2000) Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res 60(6):1595–1603PubMed

40.

Rosty C, Ueki T, Argani P, Jansen M, Yeo CJ, Cameron JL, Hruban RH, Goggins M (2002) Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. Am J Pathol 160(1):45–50. doi:10.1016/S0002-9440(10)64347-7 PubMedPubMedCentralCrossRef

41.

Platt-Higgins AM, Renshaw CA, West CR, Winstanley JH, De Silva Rudland S, Barraclough R, Rudland PS (2000) Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer. Int J Cancer J Int Du Cancer 89(2):198–208CrossRef

42.

Li C, Zhang F, Wang Y (2010) S100A proteins in the pathogenesis of experimental corneal neovascularization. Mol Vis 16:2225–2235

43.

Mayr B, Montminy M (2001) Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2(8):599–609. doi:10.1038/35085068 PubMedCrossRef

44.

Peshavariya HM, Liu GS, Chang CW, Jiang F, Chan EC, Dusting GJ (2014) Prostacyclin signaling boosts NADPH oxidase 4 in the endothelium promoting cytoprotection and angiogenesis. Antioxid Redox Signal 20(17):2710–2725. doi:10.1089/ars.2013.5374 PubMedCrossRef

45.

Darashchonak N, Koepsell B, Bogdanova N, von Versen-Hoynck F (2014) Adenosine A2B receptors induce proliferation, invasion and activation of cAMP response element binding protein (CREB) in trophoblast cells. BMC Pregnancy Childbirth 14:2. doi:10.1186/1471-2393-14-2 PubMedPubMedCentralCrossRef

46.

Barresi V, Branca G, Caffo M, Tuccari G (2015) p-CREB expression in human meningiomas: correlation with angiogenesis and recurrence risk. J Neuro-Oncol 122(1):87–95. doi:10.1007/s11060-014-1706-9 CrossRef

47.

Meller R, Minami M, Cameron JA, Impey S, Chen D, Lan JQ, Henshall DC, Simon RP (2005) CREB-mediated Bcl-2 protein expression after ischemic preconditioning. J Cereb Blood Flow Metab 25(2):234–246. doi:10.1038/sj.jcbfm.9600024 PubMedCrossRef

48.

Wang S, Sorenson CM, Sheibani N (2005) Attenuation of retinal vascular development and neovascularization during oxygen-induced ischemic retinopathy in Bcl-2−/− mice. Dev Biol 279(1):205–219. doi:10.1016/j.ydbio.2004.12.017 PubMedCrossRef

49.

Hui K, Yang Y, Shi K, Luo H, Duan J, An J, Wu P, Ci Y, Shi L, Xu C (2014) The p38 MAPK-regulated PKD1/CREB/Bcl-2 pathway contributes to selenite-induced colorectal cancer cell apoptosis in vitro and in vivo. Cancer Lett 354(1):189–199. doi:10.1016/j.canlet.2014.08.009 PubMedCrossRef

50.

Fujii M, Sherchan P, Soejima Y, Hasegawa Y, Flores J, Doycheva D, Zhang JH (2014) Cannabinoid receptor type 2 agonist attenuates apoptosis by activation of phosphorylated CREB-Bcl-2 pathway after subarachnoid hemorrhage in rats. Exp Neurol 261:396–403. doi:10.1016/j.expneurol.2014.07.005 PubMedCrossRef

51.

Shankar E, Krishnamurthy S, Paranandi R, Basu A (2010) PKCepsilon induces Bcl-2 by activating CREB. Int J Oncol 36(4):883–888PubMed

52.

Boland K, Flanagan L, Prehn JH (2013) Paracrine control of tissue regeneration and cell proliferation by Caspase-3. Cell Death Dis 4:e725. doi:10.1038/cddis.2013.250 PubMedPubMedCentralCrossRef

53.

Nassar A, Lawson D, Cotsonis G, Cohen C (2008) Survivin and caspase-3 expression in breast cancer: correlation with prognostic parameters, proliferation, angiogenesis, and outcome. Appl Immunohistochem Molecular Morphol: AIMM/Off Publ Soc Appl Immunohistochem 16(2):113–120. doi:10.1097/PAI.0b013e318032ea73 CrossRef

54.

Volm M, Mattern J, Koomagi R (1999) Inverse correlation between apoptotic (Fas ligand, caspase-3) and angiogenic factors (VEGF, microvessel density) in squamous cell lung carcinomas. Anticancer Res 19(3A):1669–1671PubMed

55.

Wang H, Chen X (2013) Effects of a Rho kinase inhibitor on the sequential expression of ICAM-1, HIF-1alpha, Bcl-2 and caspase-3 in the retina of rats with oxygen-induced retinopathy. Int J Mol Med 32(2):457–463. doi:10.3892/ijmm.2013.1410 PubMed

Title: S100A4 gene silencing in oxygen-induced ischemic retinopathy inhibits retinal neovascularization via down-regulation of CREB expression
Authors: Gumeng Cheng
Kailin Tian
Lu Zhang
Ning Yang
Yiqiao Xing
Tao He
Publication date: 01-01-2016
Publisher: Springer Berlin Heidelberg
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 1/2016
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-015-3158-0

At a glance: The STEP trials

Springer Medicine

S100A4 gene silencing in oxygen-induced ischemic retinopathy inhibits retinal neovascularization via down-regulation of CREB expression

Abstract

Purpose

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2016

Vascular endothelial growth factor plasma levels before and after treatment of retinopathy of prematurity with ranibizumab

Science and art in retinopathy of prematurity diagnosis

Risk factors of persistent diplopia following secondary intraocular lens implantation in patients with sensory strabismus from uncorrected monocular aphakia

A new principle for the standardization of long paragraphs for reading speed analysis

Vitreo-retinal relationship and post-operative outcome of macular hole repair in eyes with high myopia

Modified corneal incisions in intraoperative floppy iris syndrome (IFIS)-prone patients